Who makes Nelmastobart and Docetaxel?

Nelmastobart and Docetaxel is developed by STCube, Inc..

What development phase is Nelmastobart and Docetaxel in?

Nelmastobart and Docetaxel is in Phase 2.

Last reviewed 2026-04-19 · How we verify

Nelmastobart and Docetaxel

STCube, Inc. · Phase 2 active Small molecule

At a glance

Generic name	Nelmastobart and Docetaxel
Sponsor	STCube, Inc.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Nelmastobart and Docetaxel CI brief — competitive landscape report
Nelmastobart and Docetaxel updates RSS · CI watch RSS
STCube, Inc. portfolio CI